Left ventricular diastolic dysfunction in patients with dermatomyositis without clinically evident cardiovascular disease

Journal of Rheumatology

Volumn 41, Issue 3, 2014, Pages 495-500

  Wang, Han ^a,b   Liu, Han Xiong ^a   Wang, Yin Li ^a   Yu, Xiu Qiong ^a   Chen, Xian Xiang ^a,b   Cai, Lin ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b HUBEI UNIVERSITY OF MEDICINE   (China)

Author keywords

Dermatomyositis; Diastolic dysfunction; Echocardiography

Indexed keywords

GLUCOSE; URIC ACID;

ADULT; AGED; ARTICLE; CARDIOVASCULAR PARAMETERS; CLINICAL ASSESSMENT; CONTROLLED STUDY; DERMATOMYOSITIS; DIASTOLIC BLOOD PRESSURE; DIASTOLIC FLOW VELOCITY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE MARKER; DOPPLER ECHOCARDIOGRAPHY; FEMALE; GLUCOSE BLOOD LEVEL; HEART RATE; HUMAN; LEFT VENTRICULAR DIASTOLIC DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MITRAL ANNULAR EARLY DIASTOLIC VELOCITY; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; URIC ACID BLOOD LEVEL;

DERMATOMYOSITIS; DIASTOLIC DYSFUNCTION; ECHOCARDIOGRAPHY;

ADOLESCENT; ADULT; AGED; BLOOD FLOW VELOCITY; DERMATOMYOSITIS; DIASTOLE; DISEASE PROGRESSION; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HUMANS; MALE; MIDDLE AGED; VENTRICULAR DYSFUNCTION, LEFT; YOUNG ADULT;

EID: 84895438893     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.130346     Document Type: Article

References (34)

1. Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet 2003;362:71-982.
2. Gupta R, Wayangankar SA, Targoff IN, Hennebry TA. Clinical cardiac involvement in idiopathic inflammatory myopathies: a systematic review. Int J Cardiol 2011;148:261-70.
3. Danko K, Ponyi A, Constantin T, Borgulya G, Szegedi G. Long term survival of patients with idiopathic inflammatory myopathies according to clinical features: a longitudinal study of 162 cases. Medicine 2004;83:35-42. (Pubitemid 38124854)
4. Askari AD. Cardiac abnormalities in inflammatory myopathy. Clin Rheum Dis 1984;10:131-49.
5. Lundberg IE. The heart in dermatomyositis and polymyositis. Rheumatology 2006;45 Suppl 4:iv18-21. (Pubitemid 44446758)
6. Lundberg IE. Cardiac involvement in autoimmune myositis and mixed connective tissue disease. Lupus 2005;14:708-12. (Pubitemid 41413296)
7. Bazzani C, Cavazzana I, Ceribelli A, Vizzardi E, Dei Cas L, Franceschini F. Cardiological features in idiopathic inflammatory myopathies. J Cardiovasc Med 2010;11:906-11.
8. Tzelepis GE, Kelekis NL, Plastiras SC, Mitseas P, Economopoulos N, Kampolis C, et al. Pattern and distribution of myocardial fibrosis in systemic sclerosis: a delayed enhanced magnetic resonance imaging study. Arthritis Rheum 2007;56:3827-36. (Pubitemid 350100715)
9. Gonzalez-Lopez L, Gamez-Nava JI, Sanchez L, Rosas E, Suarez-Almazor M, Cardona-Munoz C, et al. Cardiac manifestations in dermato-polymyositis. Clin Exp Rheumatol 1996;14:373-9. (Pubitemid 26257588)
10. Gottdiener JS, Sherber HS, Hawley RJ, Engel WK. Cardiac manifestations in polymyositis. Am J Cardiol 1978;41:1141-9. (Pubitemid 8371752)
11. Taylor AJ, Wortham DC, Burge JR, Rogan KM. The heart in polymyositis: a prospective evaluation of 26 patients. Clin Cardiol 1993;16:802-8. (Pubitemid 23335118)
12. Agrawal CS, Behari M, Shrivastava S, Ahuja GK, Bhandari S, Kothari SS. The heart in polymyositis-dermatomyositis. J Neurol 1989;236:249-50. (Pubitemid 19144811)
13. Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl J Med 1975;292:44-7.
14. Bode RK, Klein-Gitelman MS, Miller ML, Lechman TS, Pachman LM. Disease activity score for children with juvenile dermatomyositis: reliability and validity evidence. Arthritis Rheum 2003;49:7-15. (Pubitemid 36286124)
15. Schwartz T, Sanner H, Husebye T, Flatø B, Sjaastad I. Cardiac dysfunction in juvenile dermatomyositis: a case-control study. Ann Rheum Dis 2011;70:766-71.
16. Domsic R, Maksimowicz-McKinnon K, Manzi S. Prevention of cardiovascular disease in patients with rheumatic diseases. Best Pract Res Clin Rheumatol 2006;20:741-56. (Pubitemid 44350116)
17. Rexhepaj N, Bajraktari G, Berisha I, Beqiri A, Shatri F, Hima F, et al. Left and right ventricular diastolic functions in patients with rheumatoid arthritis without clinically evident cardiovascular disease. Int J Clin Pract 2006;60:683-8. (Pubitemid 43811648)
18. Lie JT. Cardiac manifestations in polymyositis/dermatomyositis: how to get to the heart of the matter. J Rheumatol 1995;22:809-11.
19. Denbow CE, Lie JT, Tancredi RG, Bunch TW. Cardiac involvement in polymyositis. Arthritis Rheum 1979;22:1088-92.
20. Mavrogeni S. Myocarditis in systemic diseases and the role of cardiovascular magnetic resonance. Hellenic J Cardiol 2012;53:142-7.
21. Allanore Y, Vignaux O, Arnaud L, Puéchal X, Pavy S, Duboc D, et al. Effects of corticosteroids and immunosuppressors on idiopathic inflammatory myopathy related myocarditis evaluated by magnetic resonance imaging. Ann Rheum Dis 2006;65:249-52. (Pubitemid 43132003)
22. Haupt HM, Hutchins GM. The heart and cardiac conduction system in polymyositis-dermatomyositis: a clinicopathologic study of 16 autopsied patients. Am J Cardiol 1982;50:998-1006. (Pubitemid 13232021)
23. Oka M, Raasakka T. Cardiac involvement in polymyositis. Scand J Rheumatol 1978;7:203-8. (Pubitemid 9102969)
24. Riemekasten G, Opitz C, Audring H, Barthelmes H, Meyer R, Hiepe F, et al. Beware of the heart, the multiple picture of cardiac involvement in myositis. Rheumatol 1999;38:1153-7. (Pubitemid 29537341)
25. Han L, Bai X, Lin H, Sun X, Chen X. Gender differences in the relationship between age-related carotid intima-media thickness and cardiac diastolic function in a healthy Chinese population. J Card Fail 2013;19:325-32.
26. Alpaslan M, Onrat E, Evcik D. Doppler echocardiographic evaluation of ventricular function in patients with rheumatoid arthritis. Clin Rheumatol 2003;22:84-8. (Pubitemid 36748853)
27. Giles JT, Malayeri AA, Fernandes V, Post W, Blumenthal RS, Bluemke D, et al. Left ventricular structure and function by cardiac magnetic resonance imaging in rheumatoid arthritis. Arthritis Rheum 2010;62:940-51.
28. Kim E, Cook-Mills J, Morgan G, Sredni ST, Pachman LM. Increased expression of vascular cell adhesion molecule 1 in muscle biopsy samples from juvenile dermatomyositis patients with short duration of untreated disease is regulated by miR-126. Arthritis Rheum 2012;64:3809-17.
29. Pachman LM, Abbott K, Sinacore JM, Amoruso L, Dyer A, Lipton R, et al. Duration of illness is an important variable for untreated children with juvenile dermatomyositis. J Pediatr 2006;148:247-53. (Pubitemid 43286768)
30. Zhao Y, Fedczyna TO, McVicker V, Caliendo J, Li H, Pachman LM. Apoptosis in the skeletal muscle of untreated children with juvenile dermatomyositis: impact of duration of untreated disease. Clin Immunol 2007;125:165-72. (Pubitemid 47570110)
31. Yazici D, Tokay S, Aydin S, Toprak A, Inanc N, Khan SR, et al. Echocardiographic evaluation of cardiac diastolic function in patients with rheumatoid arthritis: 5 years of follow-up. Clin Rheumatol 2008;27:647-50.
32. Abdul Muizz AM, Mohd Shahrir MS, Sazliyana S, Oteh M, Shamsul AS, Hussein H. A cross-sectional study of diastolic dysfunction in rheumatoid arthritis and its association with disease activity. Int J Rheum Dis 2011;14:18-30.
33. Schwartz T, Sanner H, Gjesdal O, Flatø B, Sjaastad I. In juvenile dermatomyositis, cardiac systolic dysfunction is present after long-term follow-up and is predicted by sustained early skin activity. Ann Rheum Dis 2013 Jul 23 (E-pub ahead of print).
34. Mavrogeni S, Dimitroulas T, Kitas GD. Multimodality imaging and the emerging role of cardiac magnetic resonance in autoimmune myocarditis. Autoimmun Rev 2012;12:305-12.